Contrast-Induced Nephropathy in Interventional Cardiovascular Medicine

Contrast nephropathy is a major and growing problem. It is the third most common cause of in-hospital acute renal failure and is associated with significant in-hospital mortality, long-term mortality, increased risk of in-hospital major adverse cardiac events as well as prolonged hospital stay and increased costs of health care.

The first of its kind to discuss the potentially mortal problems with contrast agent-induced nephropathy, this important work focuses on the challenge of contrast nephropathy in patients undergoing diagnostic and interventional procedures in the cardiac catheterization laboratory, such as coronary and peripheral angiography, percutaneous coronary and peripheral interventions.

Bringing together experts from the specialties and subspecialties of cardiology, interventional cardiology, radiology and nephrology, Contrast-Induced Nephropathy is a useful resource not only for interventional cardiologists but also for other professionals involved in the care of high-risk patients undergoing contrast-associated procedures.

1. Pathophysiology of Contrast-Agent-Induced Nephropathy 2. Coronary Risk and Chronic Kidney Disease 3. Epidemiology and Predictors of Contrast-Agent-Induced Nephropathy 4. Clincal Features and Prognostic Implications of Contract-Agent-Induced Nephropathy 5. Effects of Renal Insufficiency and Contrast Nephropathy on Prognosis and Treatment Outcomes of Acute Coronary Syndromes 6. Renovascular Disease in Patients with Coronary Artery Disease 7. Prevention of Contrast-Agent-Induced Nephropathy with Hydration 8. Contrast Media: Physiochemical Properties, Physiological Effects and Selection 9. Pharmacological Prophylaxis 10. Renal Replacement Therapies 11. Novel Preventive Strategies for Contrast-Induced-Nephropathy 12. CO2 Angiography and Magnetic Resonance in Imaging and Interventions